Jinge Zhao

机构：Sichuan University, West China Hospital of Sichuan University, Orion Corporation (United Kingdom)

发表论文 11 篇 · 总被引 46 次 · h-index 2

代表论文

• Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma (2023 · Genome Medicine · 被引 30)
• Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets (2025 · Nature Communications · 被引 14)
• Single-port versus multi-port robotic-assisted partial nephrectomy in perioperative, oncological, and renal function outcomes: a systematic review and meta-analysis (2026 · Journal of Robotic Surgery · 被引 1)
• Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancer (2026 · The Journal of Pathology Clinical Research · 被引 1)
• Abstract 4552: BSI-730, a first-in-class HER2xPD-L1 bi-specific ADC, demonstrates potent anti-tumor activity in HER2-low models via selective tumor cell killing and immune modulation (2026 · Cancer Research)
• Abstract 1763: BSI-737, a best-in-class B7H3xPD-L1 bi-specific ADC with dual function to eliminate tumor via selective killing and exacerbated anti-tumor immune response (2026 · Cancer Research)